EcoR1 Capital
San Francisco, Californiaecor1cap.com
Overview
EcoR1 Capital is a biotech-focused investment advisory firm that invests in public and private biotechnology companies globally.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Immunic | Mar 2026 | Post-IPO Financing | Co-investor |
| Diagonal Therapeutics | Jan 2026 | Series B | Co-investor |
| CAMP4 | Dec 2025 | Follow-on Offering | Co-investor |
| Attovia Therapeutics | Apr 2025 | Series C | Co-investor |
| Neurogene | Nov 2024 | PIPE | Co-investor |
Key People
Adam Schayowitz
Operating Partner
Caroline Stout
Partner
Catherine McWilliams
Director Of Partner Relations
Basheer Zada
Principal
Sarah Spencer
Principal
Scott Platshon
Investor
Maddie Gehrich
Investor Relations Associate
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
